9 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the Evaluation ... Management #Diagnosis ... #Management #Hematology ... #Workup #Algorithm ... #Ddxof
Evaluation and Management of Pediatric Fever #Diagnosis #Management #EM #Peds #Fever #Workup #Evaluation #Discharge #Admission #Algorithm
of Pediatric Fever ... #Diagnosis #Management ... #EM #Peds #Fever ... #Workup #Evaluation ... Admission #Algorithm #Ddxof
Algorithm for the differentiation between simple and complex febrile seizures. Guidelines for evaluation of each. #Diagnosis
Guidelines for evaluation ... #Diagnosis #Management ... #EM #Neuro #Peds ... FebrileSeizure #Fever ... Seizure #Algorithm #Workup
Serious Bacterial Illness (SBI):
1) UTI and pyelonephritis
Most common cause of SBI
Accounts for 3-8% of uncharacterized fevers
Female
pyelonephritis Most common cause ... uncharacterized fevers ... Consider BCx, CSF evaluation ... #Peds #EM #Classification ... #Ddxof
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Erythematosus (SLE) - Diagnosis ... 1 • Clinical Manifestations ... • Immunologic Workup ... Positive in 60-80% of cases ... Erythematosus #Diagnosis
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
• Immunologic Workup ... Discontinuation of causal ... • Immunologic Workup ... comparison #table #rheumatology ... #diagnosis #management
Algorithm for the Evaluation of Kawasaki and Incomplete Kawasaki Disease:
Diagnosis
* Fever >5d
* Criteria (4/5)
  -
Algorithm for the Evaluation ... * Fever >5d * ... #Peds #Pediatrics ... Disease #Criteria #Workup ... #Algorithm #Ddxof
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
• Clinical: fever ... Drugs, Unknown cause ... life-threatening manifestations ... inhibitors under evaluation ... treatment #summary #rheumatology
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
• Immunologic Workup ... Discontinuation of causal ... cutaneous-DIL • Evolution ... DrugInduced #Lupus #DIL #rheumatology ... #diagnosis #treatment